Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000490824 | SCV000580167 | pathogenic | Hereditary cancer-predisposing syndrome | 2016-04-13 | criteria provided, single submitter | clinical testing | The c.3789_3790insTAGC pathogenic mutation (also known as p.L1264*), located in coding exon 8 of the MSH6 gene, results from an insertion of 4 nucleotides at position 3789, causing a translational frameshift and an alternate stop codon at position 1264. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Baylor Genetics | RCV003464046 | SCV004196361 | likely pathogenic | Endometrial carcinoma | 2021-08-16 | criteria provided, single submitter | clinical testing |